We are live on ! Find out more
SFI

Susquehanna Fundamental Investments Portfolio holdings

AUM $2.67B
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+21.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.44B
AUM Growth
-$36M
Cap. Flow
+$87.8M
Cap. Flow %
1.61%
Top 10 Hldgs %
10.05%
Holding
1,994
New
353
Increased
482
Reduced
698
Closed
317

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$97M
2
BA icon
Boeing
BA
+$20.9M
3
XOM icon
ExxonMobil
XOM
+$19.6M
4
LI icon
Li Auto
LI
+$19.6M
5
CTAS icon
Cintas
CTAS
+$17.5M

Sector Composition

Rank Sector Weight
1 Technology 16.36%
2 Financials 13.02%
3 Consumer Discretionary 11.68%
4 Healthcare 11.6%
5 Industrials 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALDX icon
1476
Aldeyra Therapeutics
ALDX
$91.7M
$242K ﹤0.01%
27,531
-8,290
-23% -$76.1K
COLL icon
1477
Collegium Pharmaceutical
COLL
$912M
$241K ﹤0.01%
+12,200
New +$264K
OTLK icon
1478
Outlook Therapeutics
OTLK
$162M
$241K ﹤0.01%
+5,555
New +$268K
CVM icon
1479
CEL-SCI Corp
CVM
$25.5M
$240K ﹤0.01%
+727
New +$212K
BATRK icon
1480
Atlanta Braves Holdings Series B
BATRK
$3.42B
$239K ﹤0.01%
9,061
-16,101
-64% -$424K
CTBI icon
1481
Community Trust Bancorp
CTBI
$1.43B
$238K ﹤0.01%
+5,650
New +$229K
SMSI icon
1482
Smith Micro Software
SMSI
$16.7M
$238K ﹤0.01%
+1,230
New +$249K
BANF icon
1483
BancFirst
BANF
$3.87B
$237K ﹤0.01%
3,945
-6,002
-60% -$343K
ENTA icon
1484
Enanta Pharmaceuticals
ENTA
$399M
$237K ﹤0.01%
4,169
-4,495
-52% -$222K
TRTX
1485
TPG RE Finance Trust
TRTX
$616M
$237K ﹤0.01%
19,135
-2,301
-11% -$29.4K
CTLT
1486
DELISTED
CATALENT, INC.
CTLT
$237K ﹤0.01%
1,779
-29,085
-94% -$3.63M
RNAM
1487
DELISTED
Avidity Biosciences
RNAM
$235K ﹤0.01%
+9,550
New +$208K
NFH
1488
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$235K ﹤0.01%
+20,900
New +$233K
AYTU icon
1489
AYTU BioPharma
AYTU
$25.3M
$233K ﹤0.01%
4,043
+1,302
+48% +$97.7K
TVTY
1490
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$232K ﹤0.01%
+10,040
New +$238K
RAVN
1491
DELISTED
Raven Industries Inc
RAVN
$232K ﹤0.01%
4,023
-21,842
-84% -$1.27M
PTGX icon
1492
Protagonist Therapeutics
PTGX
$9.86B
$231K ﹤0.01%
13,015
-21,605
-62% -$921K
MXL icon
1493
MaxLinear
MXL
$7.03B
$230K ﹤0.01%
4,673
-4,458
-49% -$216K
RLAY icon
1494
Relay Therapeutics
RLAY
$4.36B
$230K ﹤0.01%
+7,300
New +$246K
QUOT
1495
DELISTED
Quotient Technology Inc
QUOT
$230K ﹤0.01%
39,500
+22,803
+137% +$191K
CLR
1496
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$228K ﹤0.01%
+4,940
New +$186K
ADAP
1497
DELISTED
Adaptimmune Therapeutics
ADAP
$227K ﹤0.01%
43,960
-75,790
-63% -$340K
MIST icon
1498
Milestone Pharmaceuticals
MIST
$134M
$227K ﹤0.01%
39,802
-11,700
-23% -$66K
RGP icon
1499
Resources Connection
RGP
$146M
$227K ﹤0.01%
14,405
-10,515
-42% -$158K
SAFE
1500
DELISTED
Safehold Inc.
SAFE
$227K ﹤0.01%
+3,160
New +$268K

Similar funds

Susquehanna Fundamental Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Susquehanna Fundamental Investments held 1,994 positions worth $5.44B, down 0.66% from $5.48B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Susquehanna Fundamental Investments's Q3 2021 filing shows 353 new, 482 increased, 698 reduced and 317 closed positions. Its largest new stake was ExxonMobil: 344,432 shares worth $20.3M. The largest sale was T-Mobile US, an estimated $50.2M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Susquehanna Fundamental Investments's largest Q3 2021 buy was ExxonMobil: 344,432 shares worth $20.3M.
  • Susquehanna Fundamental Investments added most to AT&T in Q3 2021, an estimated $97M increase.
  • Susquehanna Fundamental Investments's biggest Q3 2021 reduction was Emerson Electric, cutting an estimated $19.5M.
  • Susquehanna Fundamental Investments fully exited T-Mobile US in Q3 2021, selling an estimated $50.2M.
  • Susquehanna Fundamental Investments's ten largest holdings make up 10% of its $5.44B portfolio in Q3 2021.
  • Susquehanna Fundamental Investments opened 353 new positions and closed 317 in Q3 2021.
  • Susquehanna Fundamental Investments's portfolio value fell 0.66% quarter-over-quarter to $5.44B.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.